Back to BAKER BROS. ADVISORS LP

DSGN
Showing 8 of 21 quarters

Position history for BAKER BROS. ADVISORS LP's holdings in DESIGN THERAPEUTICS INC

BAKER BROS. ADVISORS LP holds 2.6M shares of DSGN (DESIGN THERAPEUTICS INC), worth $27.5M as of 2026-Q1. The position was increased (+15.8% shares). DSGN represents 0.2% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$27.5M

Current Shares

2.6M

Total Value Change

+$21.8M

Total Shares Change

+890,684

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
2.6M
+15.8%
$27.5M0.2%$10.00
40
2025-Q4
Increased
2.2M
+30.4%
$20.9M0.1%$9.79
43
2025-Q3
Unchanged
1.7M
0.0%
$12.9M0.1%$6.85
0
2025-Q2
Decreased
1.7M
-1.8%
$5.8M0.1%$3.57
0
2025-Q1
Unchanged
1.7M
0.0%
$6.7M0.1%$4.21
0
2024-Q4
Unchanged
1.7M
0.0%
$10.8M0.1%$6.17
0
2024-Q3
Increased
1.7M
+2.9%
$9.4M0.1%$5.33
28
2024-Q2
Increased
1.7M
+2.0%
$5.7M0.1%$3.35
28

Other major holders of DSGN: CITADEL ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used